AAM
BHVN

Advisors Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Advisors Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,117
Closed -$1.23M – 1533
2022
Q3 		$1.23M Sell
8,117
-555
-6% -$82.3K 0.03% 651
2022
Q2 		$1.26M Sell
8,672
-14,966
-63% -$1.91M 0.02% 667
2022
Q1 		$2.8M Sell
23,638
-1,413
-6% -$176K 0.04% 467
2021
Q4 		$3.45M Buy
25,051
+191
+0.8% +$24.3K 0.05% 421
2021
Q3 		$3.45M Buy
24,860
+825
+3% +$103K 0.05% 394
2021
Q2 		$2.33M Buy
24,035
+2,232
+10% +$181K 0.03% 549
2021
Q1 		$1.49M Buy
21,803
+1,368
+7% +$111K 0.02% 690
2020
Q4 		$1.75M Buy
20,435
+6,354
+45% +$538K 0.03% 606
2020
Q3 		$915K Buy
14,081
+8,964
+175% +$587K 0.02% 733
2020
Q2 		$374K Buy
+5,117
New +$272K 0.01% 994

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Advisors Asset Management's BHVN Position: Q4 2022 in Review

Advisors Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 8,117 shares — an estimated $1.23M sold.

Advisors Asset Management first reported a position in BHVN in Q2 2020 and held it in 10 quarters. The position peaked at $3.45M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Advisors Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Advisors Asset Management sold 8,117 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $1.23M.
  • Advisors Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 10 quarters.
  • Advisors Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.45M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Advisors Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.